rs200569046

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_001875.5(CPS1):​c.3626T>C​(p.Met1209Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000207 in 1,612,688 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1209V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 28)
Exomes 𝑓: 0.00021 ( 4 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

3
10
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 7.52

Publications

8 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 6 uncertain in NM_001875.5
BP4
Computational evidence support a benign effect (MetaRNN=0.014570594).
BP6
Variant 2-210656592-T-C is Benign according to our data. Variant chr2-210656592-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210758.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000212 (32/150840) while in subpopulation EAS AF = 0.0039 (20/5124). AF 95% confidence interval is 0.00259. There are 0 homozygotes in GnomAd4. There are 20 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.3626T>Cp.Met1209Thr
missense
Exon 30 of 38NP_001866.2
CPS1
NM_001369256.1
c.3659T>Cp.Met1220Thr
missense
Exon 31 of 39NP_001356185.1
CPS1
NM_001122633.3
c.3626T>Cp.Met1209Thr
missense
Exon 31 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.3626T>Cp.Met1209Thr
missense
Exon 30 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.3644T>Cp.Met1215Thr
missense
Exon 31 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000451903.3
TSL:1
c.2273T>Cp.Met758Thr
missense
Exon 20 of 28ENSP00000406136.2P31327-2

Frequencies

GnomAD3 genomes
AF:
0.000212
AC:
32
AN:
150732
Hom.:
0
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00389
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00107
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000488
GnomAD2 exomes
AF:
0.000545
AC:
137
AN:
251476
AF XY:
0.000508
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00576
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000207
AC:
302
AN:
1461848
Hom.:
4
Cov.:
35
AF XY:
0.000201
AC XY:
146
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00602
AC:
239
AN:
39698
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.000768
AC:
41
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111972
Other (OTH)
AF:
0.000149
AC:
9
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000212
AC:
32
AN:
150840
Hom.:
0
Cov.:
28
AF XY:
0.000272
AC XY:
20
AN XY:
73580
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41004
American (AMR)
AF:
0.00
AC:
0
AN:
15088
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3454
East Asian (EAS)
AF:
0.00390
AC:
20
AN:
5124
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4750
European-Finnish (FIN)
AF:
0.00107
AC:
11
AN:
10290
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67856
Other (OTH)
AF:
0.000483
AC:
1
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000290
Hom.:
0
Bravo
AF:
0.000227
ExAC
AF:
0.000478
AC:
58
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Congenital hyperammonemia, type I (4)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.76
BayesDel_addAF
Benign
0.0093
T
BayesDel_noAF
Pathogenic
0.24
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.77
D
Eigen
Uncertain
0.19
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.93
D
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.015
T
MetaSVM
Uncertain
0.45
D
MutationAssessor
Benign
-0.14
N
PhyloP100
7.5
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.61
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0070
D
Polyphen
0.27
B
Vest4
0.80
MVP
0.93
MPC
0.28
ClinPred
0.20
T
GERP RS
5.9
Varity_R
0.81
gMVP
0.88
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200569046; hg19: chr2-211521316; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.